0,1,2,3,4,5
,,,TABLE 1. Mutants used in study,,
Mutant,,Virus sense primer (59-39),Reverse-sense primer (59-39),Mutations,Restriction sites
M254-256,,GAGTGCGCAAGCAAAA,TTTTGCTTGCGCACTCA,A254,—c
,,TTATTACATATGG,AATTATCAGTTCTTGCC,A256,
M248-250,,GGCAGCAACTGCTAAT,TTAGCAGTTGCTGCCTC,A248,—c
,,TTGAGTGAG,TGTTGAGTAATCACC,A250,
M216,,GGACTATCGATTACAC,ATCGATAGTCCTGCTAG,D216,ClaI 645
,,ACTTGTTGGC,GTAATGCAACC,,
M144-145,,GGACTATCGATTGGTG,CCAATCGATAGTCCTTC,I144,ClaI 431
,,GTCTTTCAACCCTG,TGTACAACTGAATGG,D145,
M62,,GGTCTATAATATCGATC,CGATCGATATTATAGAC,S62,ClaI 184
,,GTTTTTATAACTGTGC,CAGCTGAAGTTCCAG,,
M96-97,,GGCCCGTTGTATCGATT,CGTAAGAATCGATACA,S96,ClaI 286
,,CTTACGATTTTTAATGC,ACGGGCCATAATAGCC,I97,
,a,,,,
M144-145-216,,,,I144,ClaI 431
,,,,D145,ClaI 645
,,,,D216,
M62-96-97b,,,,S62,ClaI 184
,,,,S96,ClaI 286
,,,,I97,
,a Obtained by combination of,the M144-145 and M216 mutants by standard cloning techniques.,,,
